A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results. (2022)

First Author: Winter M
Attributed to:  Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jbo.2022.100442

PubMed Identifier: 35800293

Publication URI: http://europepmc.org/abstract/MED/35800293

Type: Journal Article/Review

Volume: 35

Parent Publication: Journal of bone oncology

ISSN: 2212-1366